| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.033 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0051 | 0.9 |